KR101858266B1 - 친화성 크로마토그래피를 위한 세척용액 및 방법 - Google Patents

친화성 크로마토그래피를 위한 세척용액 및 방법 Download PDF

Info

Publication number
KR101858266B1
KR101858266B1 KR1020127015524A KR20127015524A KR101858266B1 KR 101858266 B1 KR101858266 B1 KR 101858266B1 KR 1020127015524 A KR1020127015524 A KR 1020127015524A KR 20127015524 A KR20127015524 A KR 20127015524A KR 101858266 B1 KR101858266 B1 KR 101858266B1
Authority
KR
South Korea
Prior art keywords
arginine
protein
column
matrix
wash
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020127015524A
Other languages
English (en)
Korean (ko)
Other versions
KR20120109506A (ko
Inventor
아힘 프라우엔슈
쿠르트 빌
Original Assignee
노파르티스 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43598315&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101858266(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 노파르티스 아게 filed Critical 노파르티스 아게
Publication of KR20120109506A publication Critical patent/KR20120109506A/ko
Application granted granted Critical
Publication of KR101858266B1 publication Critical patent/KR101858266B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR1020127015524A 2009-12-18 2010-12-17 친화성 크로마토그래피를 위한 세척용액 및 방법 Active KR101858266B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28805909P 2009-12-18 2009-12-18
US61/288,059 2009-12-18
PCT/EP2010/070076 WO2011073389A1 (en) 2009-12-18 2010-12-17 Wash solution and method for affinity chromatography

Publications (2)

Publication Number Publication Date
KR20120109506A KR20120109506A (ko) 2012-10-08
KR101858266B1 true KR101858266B1 (ko) 2018-05-15

Family

ID=43598315

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127015524A Active KR101858266B1 (ko) 2009-12-18 2010-12-17 친화성 크로마토그래피를 위한 세척용액 및 방법

Country Status (18)

Country Link
US (3) US9505803B2 (enExample)
EP (2) EP2513134B1 (enExample)
JP (2) JP5909450B2 (enExample)
KR (1) KR101858266B1 (enExample)
CN (1) CN102725304B (enExample)
AU (1) AU2010332778B2 (enExample)
BR (1) BR112012014937B1 (enExample)
CA (1) CA2784278C (enExample)
DK (2) DK3272764T3 (enExample)
ES (2) ES2982297T3 (enExample)
IL (1) IL220164B (enExample)
LT (2) LT3272764T (enExample)
MX (1) MX2012007103A (enExample)
PL (2) PL2513134T3 (enExample)
PT (2) PT2513134T (enExample)
RU (1) RU2564569C2 (enExample)
SG (2) SG181771A1 (enExample)
WO (1) WO2011073389A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103276033A (zh) 2006-09-13 2013-09-04 雅培制药有限公司 细胞培养改良
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
CN105111309A (zh) * 2008-10-20 2015-12-02 Abbvie公司 使用a蛋白亲和层析分离和纯化抗体
CN104974251A (zh) 2008-10-20 2015-10-14 Abbvie公司 在抗体纯化过程中的病毒灭活
ES2982297T3 (es) * 2009-12-18 2024-10-15 Novartis Ag Método de cromatografía de afinidad
CN102712673B (zh) 2010-01-22 2014-04-30 贝林格尔.英格海姆国际有限公司 用于纯化含fc的蛋白的色谱方法
AU2012264626B2 (en) * 2011-06-01 2015-11-05 Novartis Ag Wash solution and method for affinity chromatography
WO2013055958A1 (en) 2011-10-11 2013-04-18 Genentech, Inc. Improved assembly of bispecific antibodies
ES2869396T3 (es) * 2013-05-15 2021-10-25 Medimmune Ltd Purificación de polipéptidos producidos de manera recombinante
RU2016112549A (ru) * 2013-09-05 2017-10-10 Дженентек, Инк. Способ для повторного использования хроматографии
US9546208B2 (en) 2014-01-03 2017-01-17 Bio-Rad Laboratories, Inc. Removal of impurities from protein A eluates
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
AU2016233557B2 (en) 2015-03-13 2021-06-24 Bristol-Myers Squibb Company Use of alkaline washes during chromatography to remove impurities
PL3337812T3 (pl) 2015-08-21 2021-10-11 F. Hoffmann-La Roche Ag Sposób zmniejszenia zawartości białek komórki gospodarza w chromatografii powinowactwa
JP7084301B2 (ja) * 2015-08-21 2022-06-14 エフ．ホフマン－ラ ロシュ アーゲー 低伝導率洗浄緩衝液を用いたアフィニティークロマトグラフィー精製方法
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
CN109311948B (zh) 2016-05-11 2022-09-16 思拓凡生物工艺研发有限公司 清洁和/或消毒分离基质的方法
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
EP3455243B1 (en) 2016-05-11 2021-03-24 Cytiva BioProcess R&D AB Separation matrix
EP3455240B1 (en) 2016-05-11 2025-01-01 Cytiva BioProcess R&D AB Method of storing a separation matrix
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
JP7031934B2 (ja) 2016-05-11 2022-03-08 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックス
ES2994244T3 (en) * 2016-07-25 2025-01-21 Cephalon Llc Affinity chromatography wash buffer
US12448411B2 (en) 2016-09-30 2025-10-21 Cytiva Bioprocess R&D Ab Separation method
MY199833A (en) 2017-08-17 2023-11-24 Just Evotec Biologics Inc Method of purifying glycosylated protein from host cell galectins and other contaminants
CN107793469B (zh) * 2017-10-16 2021-07-30 上海药明生物技术有限公司 一种去除宿主细胞蛋白含量的亲和纯化工艺
KR102753090B1 (ko) 2017-12-21 2025-01-14 젠자임 코포레이션 단백질 a 크로마토그래피 동안 불순물의 향상된 제거를 위한 방법
CN119881293A (zh) 2018-03-21 2025-04-25 沃特世科技公司 基于非抗体高亲和力的样品制备、吸附剂、装置和方法
SG11202009629YA (en) 2018-04-02 2020-10-29 Amgen Inc Erenumab compositions and uses thereof
US11612885B2 (en) * 2018-05-08 2023-03-28 Waters Technologies Corporation Methods, compositions and kits useful for pH gradient cation exchange chromatography
EP3837273B1 (en) * 2018-08-14 2025-09-24 Bristol-Myers Squibb Company Improved protein recovery
CA3150215A1 (en) * 2019-10-08 2021-04-15 Stefano Menegatti Immunoglobulin purification peptides and their use
AU2021244846A1 (en) * 2020-03-27 2022-11-24 HaemaLogiX Ltd Composition and method
EP4143203A1 (en) * 2020-04-27 2023-03-08 Alexion Pharmaceuticals, Inc. Protein a chromatography purification of an antibody
CN112827217A (zh) * 2020-12-29 2021-05-25 苏州良辰生物医药科技有限公司 一种层析柱清洗液及其应用
KR20250121073A (ko) * 2022-12-12 2025-08-11 하. 룬드벡 아크티에셀스카브 단백질 정제에서 아르기닌 세척
WO2024233992A2 (en) * 2023-05-11 2024-11-14 Trophogen, Inc. Methods of manufacturing highly glycosylated glycoprotein hormones and their analogs

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008031020A2 (en) * 2006-09-08 2008-03-13 Wyeth Arginine wash in protein purification using affinity chromatography

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704366A (en) 1984-06-22 1987-11-03 Bio-Rad Laboratories, Inc. Process for binding IgG to protein A
US4857320A (en) * 1987-02-19 1989-08-15 Monsanto Company Method of enhancing the solubility of tissue plasminogen activator
JPH01238534A (ja) * 1988-03-17 1989-09-22 Mitsui Toatsu Chem Inc エンドトキシンの除去方法
US5429746A (en) 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
ES2335365T3 (es) 1996-11-27 2010-03-25 Genentech, Inc. Purificacion por afinidad de polipeptido en una matriz de proteina a.
KR100960211B1 (ko) 1998-05-06 2010-05-27 제넨테크, 인크. 이온 교환 크로마토그래피에 의한 단백질 정제 방법
IL139609A (en) 1998-06-01 2006-06-11 Genentech Inc Separation of polypeptides monomers
JP4391086B2 (ja) 2001-03-09 2009-12-24 中外製薬株式会社 タンパク質精製方法
ATE333469T1 (de) 2001-06-05 2006-08-15 Genetics Inst Llc Verfahren zur reinigung hochanionischer proteine
AU2003210802B2 (en) 2002-02-05 2009-09-10 Genentech Inc. Protein purification
KR101119448B1 (ko) 2002-09-11 2012-03-15 추가이 세이야쿠 가부시키가이샤 단백질 정제 방법
MXPA05004290A (es) * 2002-10-24 2005-11-23 Enos Pharmaceuticals Inc Formulaciones de l-arginina de liberacion sostenida, y metodos para su fabricacion y uso.
NZ540562A (en) * 2002-11-26 2008-04-30 Pdl Biopharma Inc Therapeutic chimeric and humanized antibodies directed against alpha5beta1 integrin, methods for purification of these antibodies, and their use in treating conditions comprising undesirable tissue angiogenesis
ATE424215T1 (de) * 2003-01-08 2009-03-15 Novartis Vaccines & Diagnostic Stabilisierte wässrige zusammensetzungen mit gewebefaktorinhibitor (tfpi) oder gewebefaktorinhibitor-variante
DK1601697T3 (da) 2003-02-28 2007-10-01 Lonza Biologics Plc Oprensning af antistof ved protein A- og ionbytningskromatografi
GB0304576D0 (en) 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
EP1678208B1 (en) 2003-10-27 2013-05-15 Wyeth LLC Removal of high molecular weight aggregates using hydroxyapatite chromatography
US8084032B2 (en) * 2004-01-21 2011-12-27 Ajinomoto Co., Inc. Purification method which prevents denaturation of an antibody
EP1698637B1 (en) 2005-03-03 2008-10-15 Ajinomoto Co., Inc. A method for improving recovery yield in protein purification with gel filtration chromatography using arginine
MX2007011129A (es) 2005-03-11 2007-11-06 Wyeth Corp Un metodo de cromatografia de particion debil.
EP1974215B1 (en) 2006-01-06 2017-12-27 EMD Millipore Corporation Affinity chromatography matrices and methods of making and using the same
WO2007109163A2 (en) 2006-03-16 2007-09-27 Amgen Inc Wash buffer and method of using
CN101437839A (zh) 2006-03-20 2009-05-20 米德列斯公司 蛋白质纯化
BRPI0712496A2 (pt) * 2006-06-02 2012-09-25 Wyeth Corp peptìdeo isolado, composição compreendendo o referido peptìdeo, ácido nucléico isolado e métodos de purificar uma proteìna na superfamìlia do fator beta de transformação do crescimento (tgf-?) e de estabilizar uma solução contendo uma proteìna na superfamìlia tgf-b.
US7754689B2 (en) * 2006-06-02 2010-07-13 Wyeth Llc Finger-1 peptide analogs of the TGF-β superfamily
JP2010501623A (ja) 2006-08-28 2010-01-21 アレス トレーディング ソシエテ アノニム Ｆｃ含有タンパク質の精製法
AU2008206923A1 (en) 2007-01-17 2008-07-24 Merck Serono S.A. Process for the purification of Fc-containing proteins
AU2008256411B2 (en) 2007-06-01 2013-08-22 F. Hoffmann-La Roche Ag Immunoglobulin purification
WO2009138484A2 (en) 2008-05-15 2009-11-19 Novo Nordisk A/S Antibody purification process
US20110144311A1 (en) 2008-08-14 2011-06-16 Rebecca Chmielowski Methods for purifying antibodies using protein a affinity chromatography
ES2982297T3 (es) * 2009-12-18 2024-10-15 Novartis Ag Método de cromatografía de afinidad
AU2012264626B2 (en) 2011-06-01 2015-11-05 Novartis Ag Wash solution and method for affinity chromatography

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008031020A2 (en) * 2006-09-08 2008-03-13 Wyeth Arginine wash in protein purification using affinity chromatography

Also Published As

Publication number Publication date
AU2010332778A1 (en) 2012-07-19
KR20120109506A (ko) 2012-10-08
EP3272764B1 (en) 2024-02-07
SG10201408384PA (en) 2015-01-29
PT3272764T (pt) 2024-04-24
US20190233469A1 (en) 2019-08-01
DK2513134T3 (en) 2017-12-18
PT2513134T (pt) 2017-12-14
MX2012007103A (es) 2012-07-17
BR112012014937A2 (pt) 2016-03-08
US20120283416A1 (en) 2012-11-08
BR112012014937B1 (pt) 2021-01-19
EP2513134A1 (en) 2012-10-24
PL2513134T3 (pl) 2018-02-28
RU2564569C2 (ru) 2015-10-10
IL220164B (en) 2019-02-28
PL3272764T3 (pl) 2024-06-10
CN102725304A (zh) 2012-10-10
ES2982297T3 (es) 2024-10-15
SG181771A1 (en) 2012-07-30
WO2011073389A1 (en) 2011-06-23
JP2013514073A (ja) 2013-04-25
LT2513134T (lt) 2017-11-27
IL220164A0 (en) 2012-07-31
CN102725304B (zh) 2015-12-09
LT3272764T (lt) 2024-05-10
CA2784278A1 (en) 2011-06-23
ES2651065T3 (es) 2018-01-24
EP3272764A1 (en) 2018-01-24
AU2010332778B2 (en) 2015-03-19
RU2012130151A (ru) 2014-01-27
JP2016128495A (ja) 2016-07-14
JP5909450B2 (ja) 2016-04-26
EP2513134B1 (en) 2017-09-06
US9505803B2 (en) 2016-11-29
CA2784278C (en) 2019-02-26
US20170044211A1 (en) 2017-02-16
DK3272764T3 (da) 2024-05-06

Similar Documents

Publication Publication Date Title
KR101858266B1 (ko) 친화성 크로마토그래피를 위한 세척용액 및 방법
AU2012264626B2 (en) Wash solution and method for affinity chromatography
US8435527B2 (en) Purification method which prevents denaturation of an antibody
EP2649087A1 (en) Ion exchange chromatography in the presence of an amino acid
CN114901671A (zh) 用于亲和层析的新的清洗缓冲溶液

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20120615

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20151215

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20170508

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20171124

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20170508

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20171124

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20170707

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20151215

Comment text: Amendment to Specification, etc.

PX0701 Decision of registration after re-examination

Patent event date: 20180321

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

Patent event date: 20180226

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20171124

Comment text: Decision to Refuse Application

Patent event code: PX07011S01I

Patent event date: 20170707

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20151215

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20180509

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20180509

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20210428

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20220427

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20240430

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20250428

Start annual number: 8

End annual number: 8